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whereas in cereals and grasses, they do
not seem to be present, with the excep-
tion of the Avena (oat) genus. A series of
DNA and RNA blot analyses in several
cereals did not identify any orthologs of
the avenacin Sad1 gene (Qi et al., 2004).
Of note, oat possibly diverged from the
eudicots about 150 million years ago. It
has been demonstrated that extensive
gene loss of secondary metabolite syn-
thases in microorganisms could mistake
a case of common ancestry for horizontal
gene transfer or convergent evolution
(Rantala et al., 2004). However, phyloge-
netic analyses of the avenacin and thalia-
nol pathways show that the genes of each
pathway are monocot and eudicot spe-
cific, respectively. Therefore, Field and
Osbourn (2008) exclude horizontal gene
transfer from bacteria or other organisms.
Unless we are dealing with a case of ram-
pant gene duplication, rapid neofunction-
alization, and gene losses of the ancestral
genes, which actually might not be so far-
fetched for secondary metabolism, the
most reasonable scenario is convergent
evolution and repeated de novo synthesis
of the avenacin and thalianol gene clus-
ters, as suggested by the authors. Cases
of convergent evolution have been re-
ported before for regulatory networks
involved in animal development (Amout-
zias et al., 2004) or for the formation
of pathways of secondary metabolism
(Pichersky and Gang, 2000). Never-
theless, the birth of clusters of functionally
related genes with tightly coordinated ex-
pression seems a rather rare event in eu-
karyotic genomes, but, undoubtedly, up-
coming plant genomes will shed more
light on fundamental questions regarding
the structure and evolution of such gene
clusters (see for example Figure 1).
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The two metabolic sensors AMPK and SIRT1 take center stage as Fulco et al. reveal, in this issue of
Developmental Cell, the signaling mechanism by which low glucose prevents the correct development of
the myogenic program. These observations may hold some therapeutic promise against muscle wasting.One of the most amazing features of skel-
etal muscle is its high plasticity, enabling it
to respond to changes in activity, injury, or
degeneration. This plasticity is largely due
tomuscle stem cells, better known as sat-
ellite cells, residing beneath the basal
lamina of adult skeletal muscle, closely
juxtaposed against the muscle fibers (Le
Grand and Rudnicki, 2007), which have
the ability to modulate muscle growth
and differentiation. Satellite cells in adult
skeletal muscle are normally quiescent,642 Developmental Cell 14, May 2008 ª2008but proliferation and differentiation of their
descendant cells can be activated by di-
verse forms of stress, thereby playing an
essential role in muscle regeneration,
muscle hypertrophy, and postnatal mus-
cle growth.
Despite the astonishing advance during
the last few decades in our understanding
of the process of myogenesis (reviewed in
Le Grand and Rudnicki, 2007), the molec-
ular mechanisms regulating the differenti-
ation of myogenic stem cells are still un-Elsevier Inc.clear. In this issue of Developmental Cell,
a new report from Fulco et al. (2008)
examines the effects of nutrient availabil-
ity on myogenic differentiation. Interest-
ingly, the authors find that restricted glu-
cose availability prevents myogenesis.
Furthermore, the authors identify AMP-
activated protein kinase (AMPK)—a mas-
ter switch of anabolic versus catabolic
processes—as a key sensor of low glu-
cose levels during myogenesis. The con-
cept that low glucose levels leads to the
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Previewsactivation of AMPK is not new, but it
is the first time that this enzyme is
shown to be directly involved in myo-
genesis. The inhibitory role of AMPK
on myocyte differentiation is high-
lighted by results showing that myo-
tubes differentiate normally in glucose-
restricted conditions when AMPK is in-
hibited. Conversely, artificial activation
of AMPK with 5-aminoimidazole-4-car-
boxamide-1-{beta}-D-ribofuranoside
(AICAR), the standard compound used
to activate AMPK, is enough to prevent
myogenesis even in conditions when
glucose is not limiting. It is interesting
to note that AMPK has already been
shown to inhibit differentiation in other
cell models, such as adipocytes (Habi-
nowski and Witters, 2001). This new
role of AMPK would increase the al-
ready wide spectrum of functions of
this pleiotropic enzyme.
Perhaps the most relevant and unex-
pected piece of data provided by Fulco
et al. might be the mechanism by which
AMPK activation inhibits muscle differ-
entiation. The authors find that AMPK
activation causes an increase in the cel-
lular NAD+/NADH ratio, which in turn is
sensed by the NAD+-dependent type III
histone deacetylase SIRT1. In a previ-
ous study, the authors have already impli-
cated SIRT1 as a negative regulator of
myogenesis (Fulco et al., 2003). When
NAD+ levels increase, SIRT1 deacetylates
and inactivates MyoD, a key transcrip-
tional regulator of myogenesis, thereby
preventing the myogenic program (Fulco
et al., 2003). Therefore, the induction of
the deacetylase activity of SIRT1 seems
to be the vehicle through which AMPK
blocks myocyte differentiation. Support-
ing this hypothesis, AMPK fails to prevent
myogenesis in myocytes where SIRT1 ex-
pression has been inhibited with specific
short hairpin RNAs.
Ashappenswithmost important discov-
eries, the findings by Fulco et al. open the
door formorequestions. Further investiga-
tionwill have toestablishwhether themod-
ulation of AMPK or SIRT1 activity is rele-
vant during situations where the organism
has to build muscle ‘‘in vivo.’’ For this
purpose, it would be interesting to test
whether any of the diverse transgenic
mice models for either AMPK or SIRT1
display abnormal muscle development
and whether their response to muscle re-
generation or hypertrophic stimuli, suchas insulin-like growth factors or resistance
exercise, is compromised. Furthermore,
the effects of these metabolic sensors on
myogenesis could also be effectively
probed through the use of specific phar-
macological agonists that target either
AMPK or SIRT1 (Cool et al., 2006; Milne
et al., 2007). Moreover, other players that
could participate to mediate the effects of
glucosedeprivationonmyogenesisshould
be explored. For example, is AMPK in-
hibiting myogenesis solely through SIRT1
or are other AMPK targets, like the mTOR
pathway or the FOXO family of transcrip-
tion factors, involved? In this context, it
is relevant that both the inhibition of
mTOR (Cuenda and Cohen, 1999) and
the activation of FOXO (Hribal et al.,
2003) have been shown to negatively reg-
ulate myogenesis. Likewise, can all the
effects be attributed to a negative regula-
tion of MyoD or are there other deacetyla-
tion substrates of SIRT1 that regulate
myogenesis?
How AMPK activition modulates SIRT1
activity and whether the alterations of the
NAD+/NADH ratio are responsible for
SIRT1 activation is also particularly
Figure 1. Possible Pleiotropic Actions of
Glucose Restriction through AMPK and SIRT1
SIRT1 can deacetylate and inhibit MyoD, a key tran-
scription factor for myogenesis. Activation of AMPK
during glucose restriction triggers the activation of
SIRT1, thereby blocking the induction of the myogenic
program. However, triggering SIRT1 activity by AMPK
could also translate into the regulation of other SIRT1
deacetylation targets, such as p53, peroxisome-prolif-
erator activated receptor gamma coactivator 1a (PGC-
1a), or the FOXO family of transcription factors, leading
to a plethora of possible effects that perhaps extend
beyond the regulation of myogenesis.Developmentalimportant to establish. The authors pro-
pose that AMPK increases the expres-
sion of the nicotinamide phosphoribo-
syltransferase (Nampt), an enzyme
that catalyzes NAD+ synthesis from nic-
otinamide (Revollo et al., 2004). In line
with this hypothesis, knocking down
Nampt prevents the effects of AMPK
on the NAD+/NADH ratio and, conse-
quently, on SIRT1 activation. However,
these conclusions are based on studies
performed 36–48 hr after the pharma-
cological activation of AMPK, which
may be too long for a conclusive read-
out of enzymatic activity changes.
Therefore, it could be worthwhile to
explore whether the direct regulation
of Nampt enzymatic activity by AMPK,
and not only its expression, could con-
tribute to the observed effects. Post-
translational modifications such as
phosphorylation, and perhaps ubiquiti-
nation or acetylation, could be relevant
in this context.
Altogether, this interesting study
sheds a new light on our understanding
of myogenesis and shows the impor-
tance of nutrient-gated pathways con-
trolled by AMPK and SIRT1 in muscle
formation. AMPK and SIRT1, two of to-
day’s prime targets for the treatment of
metabolic and age-related disease, now
also become endowed with a novel and
promising role, with potential therapeutic
implication against the devastating ef-
fects of muscle wasting. We furthermore
predict that the link between AMPK and
SIRT1 signaling will become a fertile
ground for future investigations, because
it could have an impact beyond myogen-
esis (Figure 1). In fact, the modulation of
SIRT1 activity by AMPK would tie these
metabolic sensors together and perhaps
explain not only why treatment with
SIRT1 activators (Lagouge et al., 2006;
Milne et al., 2007) mimics many of the ef-
fects associated with AMPK activation
(Cool et al., 2006), but also why SIRT1
and AMPK have similar effects on metab-
olism and lifespan.
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In a recent issue ofCell, Carlile and A
for regulating and distinguishingme
and modes of regulation. In particu
meoisis I.
Meiosis is often portrayed as a specialized
cell division, conjuring the image of a
mitotic (‘‘vegetative’’) division with bells
and whistles. But when one looks in detail
at what happens, and why and how, one
is struck by the vast differences between
the vegetative and the meiotic divisions.
Many of the same proteins and processes
are used, yes, but the relationships
among them, and the regulatory wiring,
are often unrecognizable.
In a vegetative division, chromosomes
are replicated, and then at mitosis the
paired sister chromatids segregate from
each other, producing two identical cells.
This process depends in part on the pro-
tein kinase activity of a cyclin-dependent
kinase (CDK, Cdc28 in budding yeast)
bound to and activated by a B-type cyclin
(most importantly Clb2 in budding yeast).
Entry into anaphase depends on high
levels of CDK activity, and exit from ana-
phase depends on loss of this activity.
In ameiotic division (thepoint ofwhich is
to generate haploid gametes from a
diploid parent), there is likewise replication
of chromosomes, but followed by two
rounds of division. At meoisis I, one pair
of sister chromatids recombines with,
then segregates from, its homologous
pair (a division quite unlike anything seen
in vegetative cells), while at meoisis II,
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mon examine the regulation of four bu
oisis I andmeoisis II divisions, and fin
lar, Clb3 is regulated by a striking t
the sister chromatids segregate from
eachother (a division similar to the vegeta-
tive division). For both meoisis I andmeoi-
sis II, entry into anaphasedepends onhigh
CDK protein kinase activity, and exit from
anaphase depends on loss of this activity.
This complicated chromosome dance
presents the cell with a number of chal-
lenges. First, chromosome behavior in
meoisis I and meoisis II must be reliably
different. Second, there is a need to coor-
dinate loss of CDK activity to complete
meoisis I with gain of CDK activity to initi-
ate meoisis II. This second issue has been
well-studied in Xenopus (e.g., Furuno
et al., 1994; Hochegger et al., 2001).
Fortunately, budding yeast has six
B-typecyclins,Clb1 throughClb6 (reviewed
by Bloom and Cross, 2007). In principle,
these could to some extent direct the
Cdc28 cyclin-dependent kinase to phos-
phorylate different substrates, and fur-
thermore, each cyclin could be indepen-
dently regulated at various levels. In the
vegetative cell cycle, some of these
cyclins are regulated by transcription and
by protein degradation, and the various
cyclin-CDK complexes are differentially
sensitive to inhibitors such as Sic1 and
perhaps also to regulators such as Swe1
and Mih1 (reviewed by Bloom and Cross,
2007; Mendenhall and Hodge, 1998).
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dding yeast B-type cyclins, crucial
d a surprising diversity of behaviors
ranslational repression specific to
Thus, at least in principle, the differ-
ences between the vegetative, meoisis I,
and meoisis II divisions could be partly
due to differences in the properties and
regulation of the six B-type cyclins. In-
deed, genetic and other studies have
shown that the major vegetative B-type
cyclin, Clb2, is not expressed in meiosis
(Grandin and Reed, 1993) and has no
role in meiotic events. Loss of CLB1,
CLB3, or CLB4 has distinguishable mei-
otic phenotypes, though mechanistically
it is not clear why (Dahmann and Futcher,
1995).
Carlile and Amon (2008) have ad-
dressed these issues by examining the
behavior of the mRNAs, proteins, and
protein kinase activities of Clb1, Clb3,
Clb4, and Clb5 through meiosis. Key to
this examination was a new method for
producing highly synchronous meiotic
cultures, allowing meoisis I and meoisis
II to be resolved. They found a truly strik-
ing diversity in the patterns and modes
of regulation of these related cyclin genes.
For all four genes, transcription is upregu-
lated before meoisis I and downregulated
after meoisis II, and protein levels dimin-
ish with transcript levels, suggesting
protein turnover. However, novel, gene-
specific patterns of regulation by other
mechanisms also appear. With respect
